Whelton A Miller

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 11

Top Topics

Acute Myeloid Leukemia

Molecular Docking

Top Venues

Pharmaceuticals (Basel, Switzerland)

Computation (Basel, Switzerland)

International journal of molecular sciences

Current issues in molecular biology

This page only lists publications with an associated author ORCID identifier.

Publications

Carolyn N Ashley, Emmanuel Broni, Whelton A Miller
ADAR Family Proteins: A Structural Review. Current issues in molecular biology 46 (5) (2024)
Carolyn N Ashley, Emmanuel Broni, Whelton A Miller
ADAR Family Proteins: A Structural Review. Current issues in molecular biology 46 (5) (2024)
Moses N Arthur, Kristeen Bebla, Emmanuel Broni, Carolyn Ashley, Miriam Velazquez, Xianin Hua, Ravi Radhakrishnan, Samuel Kojo Kwofie, Whelton A Miller
Design of Inhibitors That Target the Menin-Mixed-Lineage Leukemia Interaction. Computation (Basel, Switzerland) 12 (1) (2023)
Emmanuel Broni, Carolyn Ashley, Miriam Velazquez, Sufia Khan, Andrew Striegel, Patrick O Sakyi, Saqib Peracha, Kristeen Bebla, Monsheel Sodhi, Samuel Kojo Kwofie, Adesanya Ademokunwa, Whelton A Miller
In Silico Discovery of Potential Inhibitors Targeting the RNA Binding Loop of ADAR2 and 5-HT2CR from Traditional Chinese Natural Compounds. International journal of molecular sciences 24 (16) (2023)
Patrick O Sakyi, Samuel Kojo Kwofie, Julius K Tuekpe, Theresa M Gwira, Emmanuel Broni, Whelton A Miller, Michael David Wilson, Richard Kwamla Amewu
Inhibiting Leishmania donovani Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Emmanuel Broni, Andrew Striegel, Carolyn Ashley, Patrick O Sakyi, Saqib Peracha, Miriam Velazquez, Kristeen Bebla, Monsheel Sodhi, Samuel Kojo Kwofie, Adesanya Ademokunwa, Sufia Khan, Whelton A Miller
Molecular Docking and Dynamics Simulation Studies Predict Potential Anti-ADAR2 Inhibitors: Implications for the Treatment of Cancer, Neurological, Immunological and Infectious Diseases. International journal of molecular sciences 24 (7) (2023)
Moses N Arthur, Kristeen Bebla, Emmanuel Broni, Carolyn Ashley, Miriam Velazquez, Xianin Hua, Ravi Radhakrishnan, Samuel Kojo Kwofie, Whelton A Miller
Design of Inhibitors That Target the Menin-Mixed-Lineage Leukemia Interaction. Computation (Basel, Switzerland) 12 (1) (2023)
Emmanuel Broni, Carolyn Ashley, Joseph Adams, Hammond Manu, Ebenezer Aikins, Mary Okom, Whelton A Miller, Michael David Wilson, Samuel Kojo Kwofie
Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors. International journal of molecular sciences 24 (7) (2023)
Patrick O Sakyi, Samuel Kojo Kwofie, Julius K Tuekpe, Theresa M Gwira, Emmanuel Broni, Whelton A Miller, Michael David Wilson, Richard Kwamla Amewu
Inhibiting Leishmania donovani Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Patrick O Sakyi, Samuel Kojo Kwofie, Julius K Tuekpe, Theresa M Gwira, Emmanuel Broni, Whelton A Miller, Michael David Wilson, Richard Kwamla Amewu
Inhibiting Leishmania donovani Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Moses N Arthur, Kristeen Bebla, Emmanuel Broni, Carolyn Ashley, Miriam Velazquez, Xianin Hua, Ravi Radhakrishnan, Samuel Kojo Kwofie, Whelton A Miller
Design of Inhibitors That Target the Menin-Mixed-Lineage Leukemia Interaction. Computation (Basel, Switzerland) 12 (1) (2023)